Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Fractionating verbal episodic memory in Alzheimer's disease.

Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Jan 15;54(2):1530-9. doi: 10.1016/j.neuroimage.2010.09.005. Epub 2010 Sep 9.

2.

Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss.

Mielke MM, Haughey NJ, Bandaru VV, Schech S, Carrick R, Carlson MC, Mori S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG.

Alzheimers Dement. 2010 Sep;6(5):378-85. doi: 10.1016/j.jalz.2010.03.014.

3.

A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease.

Laxton AW, Tang-Wai DF, McAndrews MP, Zumsteg D, Wennberg R, Keren R, Wherrett J, Naglie G, Hamani C, Smith GS, Lozano AM.

Ann Neurol. 2010 Oct;68(4):521-34. doi: 10.1002/ana.22089.

PMID:
20687206
4.

Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease.

Pievani M, Agosta F, Pagani E, Canu E, Sala S, Absinta M, Geroldi C, Ganzola R, Frisoni GB, Filippi M.

Hum Brain Mapp. 2010 Dec;31(12):1862-75. doi: 10.1002/hbm.20978. Epub 2010 Feb 16.

PMID:
20162601
5.

Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects.

Apostolova LG, Morra JH, Green AE, Hwang KS, Avedissian C, Woo E, Cummings JL, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 May 15;51(1):488-99. doi: 10.1016/j.neuroimage.2009.12.125. Epub 2010 Jan 18.

6.

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.

Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, Fagan AM, Holtzman DM, Mintun MA.

Arch Neurol. 2009 Dec;66(12):1469-75. doi: 10.1001/archneurol.2009.269.

7.

Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease.

Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ.

Brain. 2010 Feb;133(Pt 2):529-39. doi: 10.1093/brain/awp257. Epub 2009 Nov 13.

PMID:
19914928
8.

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.

Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Jul 28;73(4):294-301. doi: 10.1212/WNL.0b013e3181af79fb.

9.

Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease.

Mielke MM, Kozauer NA, Chan KC, George M, Toroney J, Zerrate M, Bandeen-Roche K, Wang MC, Vanzijl P, Pekar JJ, Mori S, Lyketsos CG, Albert M.

Neuroimage. 2009 May 15;46(1):47-55. doi: 10.1016/j.neuroimage.2009.01.054. Epub 2009 Feb 5.

10.

Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.

Kantarci K, Weigand SD, Przybelski SA, Shiung MM, Whitwell JL, Negash S, Knopman DS, Boeve BF, O'Brien PC, Petersen RC, Jack CR Jr.

Neurology. 2009 Apr 28;72(17):1519-25. doi: 10.1212/WNL.0b013e3181a2e864.

11.

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.

Mitchell AJ, Shiri-Feshki M.

Acta Psychiatr Scand. 2009 Apr;119(4):252-65. doi: 10.1111/j.1600-0447.2008.01326.x. Epub 2008 Feb 18.

PMID:
19236314
12.

Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function.

Stoub TR, Rogalski EJ, Leurgans S, Bennett DA, deToledo-Morrell L.

Neurobiol Aging. 2010 Jul;31(7):1089-98. doi: 10.1016/j.neurobiolaging.2008.08.003. Epub 2008 Sep 21.

13.

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, L Whitwell J, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW.

J Magn Reson Imaging. 2008 Apr;27(4):685-91. doi: 10.1002/jmri.21049.

14.

Landmark matching via large deformation diffeomorphisms.

Joshi SC, Miller MI.

IEEE Trans Image Process. 2000;9(8):1357-70. doi: 10.1109/83.855431.

PMID:
18262973
15.

Novel MRI techniques in the assessment of dementia.

Teipel SJ, Meindl T, Grinberg L, Heinsen H, Hampel H.

Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S58-69. doi: 10.1007/s00259-007-0703-z. Review.

PMID:
18205002
16.

Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.

Ringman JM, O'Neill J, Geschwind D, Medina L, Apostolova LG, Rodriguez Y, Schaffer B, Varpetian A, Tseng B, Ortiz F, Fitten J, Cummings JL, Bartzokis G.

Brain. 2007 Jul;130(Pt 7):1767-76. Epub 2007 May 23.

PMID:
17522104
17.

Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease.

Zhang Y, Schuff N, Jahng GH, Bayne W, Mori S, Schad L, Mueller S, Du AT, Kramer JH, Yaffe K, Chui H, Jagust WJ, Miller BL, Weiner MW.

Neurology. 2007 Jan 2;68(1):13-9.

18.

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.

Jicha GA, Parisi JE, Dickson DW, Johnson K, Cha R, Ivnik RJ, Tangalos EG, Boeve BF, Knopman DS, Braak H, Petersen RC.

Arch Neurol. 2006 May;63(5):674-81.

PMID:
16682537
19.

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L.

Lancet Neurol. 2006 Mar;5(3):228-34. Erratum in: Lancet Neurol. 2006 Apr;5(4):293.

PMID:
16488378
20.

DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking.

Jiang H, van Zijl PC, Kim J, Pearlson GD, Mori S.

Comput Methods Programs Biomed. 2006 Feb;81(2):106-16. Epub 2006 Jan 18.

PMID:
16413083

Supplemental Content

Support Center